Correlation Between BRF SA and Integrated Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BRF SA and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BRF SA and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BRF SA ADR and Integrated Biopharma, you can compare the effects of market volatilities on BRF SA and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BRF SA with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of BRF SA and Integrated Biopharma.

Diversification Opportunities for BRF SA and Integrated Biopharma

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between BRF and Integrated is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding BRF SA ADR and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and BRF SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BRF SA ADR are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of BRF SA i.e., BRF SA and Integrated Biopharma go up and down completely randomly.

Pair Corralation between BRF SA and Integrated Biopharma

Given the investment horizon of 90 days BRF SA ADR is expected to generate 0.7 times more return on investment than Integrated Biopharma. However, BRF SA ADR is 1.42 times less risky than Integrated Biopharma. It trades about 0.08 of its potential returns per unit of risk. Integrated Biopharma is currently generating about -0.01 per unit of risk. If you would invest  133.00  in BRF SA ADR on November 2, 2024 and sell it today you would earn a total of  242.00  from holding BRF SA ADR or generate 181.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy22.47%
ValuesDaily Returns

BRF SA ADR  vs.  Integrated Biopharma

 Performance 
       Timeline  
BRF SA ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BRF SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Integrated Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

BRF SA and Integrated Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BRF SA and Integrated Biopharma

The main advantage of trading using opposite BRF SA and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BRF SA position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.
The idea behind BRF SA ADR and Integrated Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine